Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

[Role of nurses in the managements of symptoms associated with spasticity in patients with multiple sclerosis].
Healthy Aging from the Perspectives of 683 Older People with Multiple Sclerosis.
Barriers experienced by patients with multiple sclerosis in seeking care for lower urinary tract symptoms.
Silver nanoparticles exhibit size-dependent differential toxicity and induce expression of syncytin-1 in FA-AML1 and MOLT-4 leukaemia cell lines.
Fatigue and depression in multiple sclerosis: pharmacological and non-pharmacological interventions.
[Monoclonal antibodies, overview and outlook of a promising therapeutic option].
Controversies in MS: All relapsing multiple sclerosis patients should be managed at a specialist clinic - Combine the best of two worlds!
Whole brain MP2RAGE-based mapping of the longitudinal relaxation time at 9.4T.
Evaluation of the benefits of treatment with TENS for neurological lower urinary tract dysfunctions.
Diffusion Weighted Imaging in Acute Attacks of Multiple Sclerosis.
Yellow fever vaccine-associated neurotropic disease (YEL-AND) - A case report.
Olig2-Targeted G-Protein-Coupled Receptor Gpr17 Regulates Oligodendrocyte Survival in Response to Lysolecithin-Induced Demyelination.
Effects of small-fiber neuropathy induced by resiniferatoxin on skin healing and axonal regrowth after burn.
Posterior lobules of the cerebellum and information processing speed at various stages of multiple sclerosis.
Weston-Hurst syndrome: a rare fulminant form of acute disseminated encephalomyelitis (ADEM).
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients.
Peripheral neuropathy in patients with myotonic dystrophy type 2.
[Multiple sclerosis vaccine: possibilities of the use of dendritic cells immunomodulatory potential].
Rationale, design, and methods of a non-interventional study to establish safety, effectiveness, quality of life, cognition, health-related and work capacity data on Alemtuzumab in multiple sclerosis patients in Germany (TREAT-MS).
Microglia Ontology and Signaling.
Cholesterol Biosynthesis Supports Myelin Gene Expression and Axon Ensheathment through Modulation of P13K/Akt/mTor Signaling.
The clinical perspective: How to personalise treatment in MS and how may biomarkers including imaging contribute to this?
The patient's perspective: How to create awareness for improving access to care and treatment of MS patients?
A case of neuromyelitis optica presenting marked pleocytosis and hypoglycorrhachia.
Finding NMO: The Evolving Diagnostic Criteria of Neuromyelitis Optica.

Pages